Navigation Links
72 Prominent Personalized Medicine Products Available; A Five-Fold Increase in Five Years
Date:11/16/2011

WASHINGTON, Nov. 16, 2011 /PRNewswire-USNewswire/ -- The Personalized Medicine Coalition (PMC) released today the 3rd edition of its landmark report, The Case for Personalized Medicine.  The report documents the growth of commercially available personalized medicine products from 13 in 2006 to 72 today, and examines opportunities for the continued development and adoption of personalized medicine as the cost of genetic sequencing declines, the pharmaceutical industry increases its commitment to personalized approaches to drug development and the public policy landscape evolves.

"The Case for Personalized Medicine documents personalized medicine's remarkable progress, evidenced by improved patient outcomes, shifting research models and increased industry investment. Yet it underscores the necessary steps required to align regulatory and reimbursement systems, thereby removing barriers that will increase personalized medicine innovation and speed its adoption," said Edward Abrahams, Ph.D., President of the Personalized Medicine Coalition.  

Highlights from the report include:

  • A compendium listing the 72 commercially available prominent personalized medicine products, grouped by indication, highlights the increasing diversity of personalized medicine drugs and diagnostic tests for conditions including arthritis, cancer, cardiovascular disease, infectious diseases, organ transplants and psychiatric disorders;
  • Real-world examples that demonstrate how personalized medicine is shifting the focus in health care from reaction to prevention, reducing trial-and-error prescribing, making drugs safer, improving health outcomes, and reducing costs to the health care system;
  • A discussion of the numerous policies which impact personalized medicine, highlighting the U.S. Food and Drug Administration's increasing commitment to personalized medicine;
  • An examination of the technologies that will continue to enable personalized medicine, including the roles of health information technology and gene sequencing in integrating clinical data to find new links between genetic variation, disease, and treatment response; and
  • Many illustrations of collaborative research designed to expand available evidence that personalized medicine can improve patient outcomes while lowering systemic costs, including how the government, academia, insurers and pharmacy benefit managers are working together to use personalized medicine to reduce adverse events.

The Case for Personalized Medicine is written for a nonscientific audience and designed to inform policymakers, researchers, and business leaders across the health care and life science industries about personalized medicine's ability to improve patient outcomes.

"The case for personalized medicine is not closed," said Brian Munroe, Chairman of PMC's Public Policy Committee.  "Regulatory, reimbursement, and educational challenges still need to be overcome to complete the transition from one-size-fits-all medicine to personalized medicine," he said.

About the Personalized Medicine Coalition
The Personalized Medicine Coalition (PMC), representing scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.  For more information on the Personalized Medicine Coalition, please visit www.PersonalizedMedicineCoalition.org.

CONTACT
Gwen Gordon, Communications Director
Phone 202-580-5019       
ggordon@personalizedmedicinecoalition.org


'/>"/>
SOURCE Personalized Medicine Coalition
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cal/OSHA Fines Prominent Pharmaceutical Firm $371,000 for Safety Violations Leading to Worker Fatality
2. SpaCapsule Manufacturer Enters Preferred Vendor Agreement With Prominent Womens Fitness Franchise
3. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
4. VirtualScopics Receives Issuance in Japan of Prominent Patent
5. E-CigaretteDirect.com Endorsed By Prominent Doctor
6. Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
7. ATS Medical Products Featured Prominently at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
8. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
9. Pharma Readiness for Personalized Medicine
10. Precision Therapeutics Named on Inc. 500
11. 5000 2011 List and Recognized for Achievements in Personalized Medicine Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - Medical ... Devices sector report, "Aesthetic Devices - Medical Devices Pipeline ... in pipeline stage. This report is ... primary research by GlobalData,s team of industry experts. ... or altered based on the availability and relevance of ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016  Otsuka Pharmaceutical ... announced that they have entered into a licensing agreement ... in the U.S. and Puerto Rico ... a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new ... --> In a Phase II clinical ...
(Date:2/8/2016)... 2016  Echo Therapeutics, Inc. (Nasdaq: ... on non-invasive continuous glucose monitoring (CGM) and ... it will host a webcast and conference ... 9:00 a.m. Eastern Time to provide a ... advancements in its CGM system, and its ...
Breaking Medicine Technology:
(Date:2/9/2016)... , ... February 09, 2016 , ... ... helping businesses recover after a disaster, announced today the acquisition of Hawaii DKI. ... Hawaii. , “Investing in like-minded companies who excel at service and ...
(Date:2/9/2016)... Cambridge, MA (PRWEB) , ... February 09, 2016 ... ... Institute (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for ... medical services covered in the report, Evaluation of the 2015 Fee Schedule ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... 10, 2016 , ... The Journal of Pain Research has published ... .” , As corresponding author Dr John F. Peppin says “Terminology matters, yet little ... chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are replete in ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
Breaking Medicine News(10 mins):